| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |